Development and validation of prognostic nomogram for T1-3N0M0 non-small cell lung cancer after curative resection

被引:2
|
作者
Mei, Weijian [1 ]
Yao, Wang [2 ]
Song, Zhengbo [3 ]
Jiao, Wenjie [4 ]
Zhu, Lianxin [5 ,6 ]
Huang, Qinghua [7 ]
An, Chaolun [8 ]
Shi, Jianguang [9 ]
Yu, Guiping [10 ]
Sun, Pingli [11 ]
Zhang, Yinbin [12 ]
Shen, Jianfei [13 ]
Xu, Chunwei [14 ]
Yang, Han [1 ]
Wang, Qian [14 ]
Zhu, Zhihua [1 ]
机构
[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Thorac Surg, State Key Lab Oncol South China,Canc Ctr, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Oncol, Guangzhou, Peoples R China
[3] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Dept Med Oncol, Hangzhou, Peoples R China
[4] Qingdao Univ, Affiliated Hosp, Dept Thorac Surg, Qingdao, Peoples R China
[5] Nanchang Univ, Med Coll, Nanchang, Peoples R China
[6] Queen Mary Univ London, London, England
[7] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Breast Surg, Nanning, Peoples R China
[8] Nantong Univ, Nantong Peoples Hosp 3, Dept Thorac Surg, Nantong, Peoples R China
[9] Zhejiang Univ, Ningbo Hosp 1, Dept Thorac Surg, Ningbo, Peoples R China
[10] Southeast Univ, Affiliated Jiangyin Hosp, Dept Thorac Surg, Jiangyin, Peoples R China
[11] Jilin Univ, Hosp 2, Dept Pathol Dept, Changchun, Peoples R China
[12] Xi An Jiao Tong Univ, Affiliated Hosp 2, Med Coll, Dept Thorac Surg, Xian, Peoples R China
[13] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Thorac Surg, Taizhou, Peoples R China
[14] Nanjing Univ Chinese Med, Suqian Hosp Chinese Med, Affiliated Hosp, Dept Resp Med, 9 Hongzehu Dong Rd, Suqian 223800, Jiangsu, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Non-small cell lung cancer; Nomogram; Curative resection; SURVIVAL; LOBECTOMY; QUALITY;
D O I
10.1186/s12885-023-11158-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundRadical resection plus lymph node dissection is a common treatment for patients with T1-3N0M0 non-small cell lung cancer (NSCLC). Few models predicted the survival outcomes of these patients. This study aimed to developed a nomogram for predicting their overall survival (OS).Materials and methodsThis study involved 3002 patients with T1-3N0M0 NSCLC after curative resection between January 1999 and October 2013. 1525 Patients from Sun Yat-sen University Cancer Center were randomly allocated to training cohort and internal validation cohort in a ratio of 7:3. 1477 patients from ten institutions were recruited as external validation cohort. A nomogram was constructed based on the training cohort and validated by internal and external validation cohort to predict the OS of these patients. The accuracy and practicability were tested by Harrell's C-indexes, calibration plots and decision curve analyses (DCA).ResultsAge, sex, histological classification, pathological T stage, and HI standard were independent factors for OS and were included in our nomogram. The C-index of the nomogram for OS estimates were 0.671 (95% CI, 0.637-0.705),0.632 (95% CI, 0.581-0.683), and 0.645 (95% CI, 0.617-0.673) in the training cohorts, internal validation cohorts, and external validation cohort, respectively. The calibration plots and DCA for predictions of OS were in excellent agreement. An online version of the nomogram was built for convenient clinical practice.ConclusionsOur nomogram can predict the OS of patients with T1-3N0M0 NSCLC after curative resection. The online version of our nomogram offer opportunities for fast personalized risk stratification and prognosis prediction in clinical practice.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Development and validation of prognostic nomogram for T1-3N0M0 non-small cell lung cancer after curative resection
    Weijian Mei
    Wang Yao
    Zhengbo Song
    Wenjie Jiao
    Lianxin Zhu
    Qinghua Huang
    Chaolun An
    Jianguang Shi
    Guiping Yu
    Pingli Sun
    Yinbin Zhang
    Jianfei Shen
    Chunwei Xu
    Han Yang
    Qian Wang
    Zhihua Zhu
    BMC Cancer, 23
  • [2] Invasion of blood vessels as significant prognostic factor in radically resected T1-3N0M0 non-small-cell lung cancer
    Gabor, S
    Renner, H
    Popper, H
    Anegg, U
    Sankin, O
    Matzi, V
    Lindenmann, J
    Jüttner, FMS
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2004, 25 (03) : 439 - 442
  • [3] Segmentectomy for c-T1N0M0 non-small cell lung cancer
    Hiroaki Nomori
    Surgery Today, 2014, 44 : 812 - 819
  • [4] Segmentectomy for c-T1N0M0 non-small cell lung cancer
    Nomori, Hiroaki
    SURGERY TODAY, 2014, 44 (05) : 812 - 819
  • [5] T2N1M0 non-small cell lung cancer:: Surgery and prognostic factors
    Padilla, J
    Calvo, V
    Peñalver, JC
    Jordá, C
    Escrivá, J
    Cerón, J
    Zarza, AG
    Pastor, J
    Blasco, E
    ARCHIVOS DE BRONCONEUMOLOGIA, 2005, 41 (08): : 430 - 433
  • [6] Survival Outcomes in Sublobar Resection for Clinical T1N0M0 Non-Small Cell Lung Cancer: Wedge Resection or Segmentectomy
    Kobayashi, Aki
    Ishikawa, Renta
    Takao, Motoshi
    Shimamoto, Akira
    Ito, Atsushi
    Shimpo, Hideto
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S301 - S302
  • [7] SURVIVAL AFTER CONSERVATIVE RESECTION FOR T1-N0-M0 NON-SMALL-CELL LUNG-CANCER
    READ, RC
    YODER, G
    SCHAEFFER, RC
    ANNALS OF THORACIC SURGERY, 1990, 49 (03): : 391 - 400
  • [8] CANCER RECURRENCE AFTER RESECTION - T1 N0 NON-SMALL CELL LUNG-CANCER
    THOMAS, P
    RUBINSTEIN, L
    ANNALS OF THORACIC SURGERY, 1990, 49 (02): : 242 - 247
  • [9] Lobectomy or wedge resection? - The comparison of outcome in patients operated on for T1N0M0 non-small cell lung cancer
    Bella, Mariusz
    Kowalewski, Janusz
    Dancewicz, Maciej
    Swiniarska, Joanna
    Malinowski, Wojciech
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA, 2007, 4 (04): : 397 - 401
  • [10] Choice of wedge resection for selected T1a/bN0M0 non-small cell lung cancer
    Xu, Zhengshui
    Ma, Zhenchuan
    Zhao, Feng
    Li, Jianzhong
    Kong, Ranran
    Li, Shaomin
    Jiang, Jiantao
    Kang, Huafeng
    Liu, Dandan
    SCIENTIFIC REPORTS, 2024, 14 (01):